findmyKOL
Clinical trialNCT04068753Active, not recruitingPhase 2Interventional

Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer

SponsorUniversity of OklahomaEnrollment66Progressive Cervix CancerRecurrent Cervix Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research study is to test the safety of Niraparib and dostarlimab as a combination treatment and see what effects (good and bad) this combination treatment has on patients with recurrent or progressive cervix cancer.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana, United States

  • Louisiana State University Health Science Center

    New Orleans, Louisiana, United States

  • Stephenson Cancer Center

    Oklahoma City, Oklahoma, United States

  • University of Virginia Cancer Center

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Niraparib →Dostarlimab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Feb 2020
Primary completion
31 Dec 2026
Completion
31 Jul 2027
Last update posted
10 Feb 2026
Registered enrollment
66
Registry id
NCT04068753
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.